<i>PIK3CA</i> Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis.

导出 OA

翻译打印收藏纠错

作者： Youjeong,Seo ^[1] ; Yeon Hee,Park ^[2] ; Jin Seok,Ahn ^[2] ; Young-Hyuck,Im ^[2] ; Seok Jin,Nam ^[3] ; Soo Youn,Cho ^[1] ; Eun Yoon,Cho ^[1]

作者单位： Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. ^[1] Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. ^[2] Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. ^[3]

关键词 Breast neoplasms ErbB-2 receptor Mutation Neoadjuvant therapy Phosphatidylinositol 3-kinases

DOI 10.4048/jbc.2018.21.e48

PMID 30607159

发布时间 2022-03-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交